21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          The Herpesviridae family consists of eight viruses, most of which infect a majority of the human population. One of the less-studied members is human herpesvirus 6 (HHV-6) ( Roseolovirus), which causes a mild, well-characterized childhood disease. Primary HHV-6 infection is followed by lifelong latency. Reactivation frequently occurs in immunocompromised patients, such as those suffering from HIV infection or cancer or following transplantation, and causes potentially life-threatening complications. In this study, we investigated the mechanisms that HHV-6 utilizes to remain undetected by natural killer (NK) cells, which are key participants in the innate immune response to infections. We revealed viral mechanisms which downregulate ligands for two powerful activating NK cell receptors: ULBP1, ULBP3, and MICB, which trigger NKG2D, and B7-H6, which activates NKp30. Accordingly, this downregulation impaired the ability of NK cells to recognize HHV-6-infected cells. Thus, we describe for the first time immune evasion mechanisms of HHV-6 that protect lytically infected cells from NK elimination.

          IMPORTANCE Human herpesvirus 6 (HHV-6) latently infects a large portion of the human population and can reactivate in humans lacking a functional immune system, such as cancer or AIDS patients. Under these conditions, it can cause life-threatening diseases. To date, the actions and interplay of immune cells, and particularly cells of the innate immune system, during HHV-6 infection are poorly defined. In this study, we aimed to understand how cells undergoing lytic HHV-6 infection interact with natural killer (NK) cells, innate lymphocytes constituting the first line of defense against viral intruders. We show that HHV-6 suppresses the expression of surface proteins that alert the immune cells by triggering two major receptors on NK cells, NKG2D and NKp30. As a consequence, HHV-6 can replicate undetected by the innate immune system and potentially spread infection throughout the body. This study advances the understanding of HHV-6 biology and the measures it uses to successfully escape immune elimination.

          Related collections

          Author and article information

          Contributors
          Role: Editor
          Journal
          J Virol
          J. Virol
          jvi
          jvi
          JVI
          Journal of Virology
          American Society for Microbiology (1752 N St., N.W., Washington, DC )
          0022-538X
          1098-5514
          17 August 2016
          14 October 2016
          1 November 2016
          : 90
          : 21
          : 9608-9617
          Affiliations
          [a ]Lautenberg Center for General and Tumor Immunology, BioMedical Research Institute Israel-Canada, Faculty of Medicine, The Hebrew University Hadassah Medical School, Jerusalem, Israel
          [b ]Pharmacology and Experimental Therapeutics Unit, Institute of Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
          [c ]Central Virology Laboratory, Chaim Sheba Medical Center, Ramat-Gan, Israel
          University of Southern California
          Author notes
          Address correspondence to Ofer Mandelboim, oferm@ 123456ekmd.huji.ac.il .

          Citation Schmiedel D, Tai J, Levi-Schaffer F, Dovrat S, Mandelboim O. 2016. Human herpesvirus 6B downregulates expression of activating ligands during lytic infection to escape elimination by natural killer cells. J Virol 90:9608–9617. doi: 10.1128/JVI.01164-16.

          Article
          PMC5068514 PMC5068514 5068514 01164-16
          10.1128/JVI.01164-16
          5068514
          27535049
          7cb10c50-64eb-4e89-aec9-c2301496415f
          Copyright © 2016, American Society for Microbiology. All Rights Reserved.
          History
          : 15 June 2016
          : 3 August 2016
          Page count
          Figures: 6, Tables: 0, Equations: 0, References: 54, Pages: 10, Words: 8157
          Funding
          This work, including the efforts of Francesca Levi-Schaffer, was funded the Bi-National Science Foundation Israel-USA. This work, including the efforts of Ofer Mandelboim, was funded by the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC grant agreement 320473-BacNK. This work, including the efforts of Ofer Mandelboim, was funded by the German-Israeli Foundation for Scientific Research and Development (GIF). This work, including the efforts of Ofer Mandelboim and Francesca Levi-Schaffer, was funded by the Israel Science Foundation (ISF). This work, including the efforts of Ofer Mandelboim, was funded by the Israel Cancer Research Fund (ICRF). This work, including the efforts of Ofer Mandelboim, was funded by the Helmholtz-Zentrum für Umweltforschung (UFZ). This work, including the efforts of Domink Schmiedel and Ofer Mandelboim, was funded by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) (FP7-PEOPLE-2012-ITN-317013).
          Categories
          Virus-Cell Interactions

          Comments

          Comment on this article